Fetal and Neonatal Monitoring Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Fetal and Neonatal Monitoring Devices Market is segmented By Product Type (Fetal Monitoring Devices, Neonatal Monitoring Devices), By Portability (Portable Monitoring Devices, Non-Portable Monitoring Devices), By End-User (Hospitals, Neonatal Clinics, Obstetrics and Gynecology Clinics, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

The Global Fetal and Neonatal Monitoring Devices Market reached US$ 8.18 billion in 2023 and is expected to reach US$ 13.6 billion by 2031 growing with a CAGR of 6.6% during the forecast period 2024-2031.

Fetal monitors and neonatal monitoring devices are medical instruments designed to track the health of a baby during pregnancy and after delivery. Fetal monitors are employed during pregnancy and childbirth to monitor the fetal heart rate and maternal uterine contractions, providing valuable insights into the baby's condition. These devices utilize ultrasound technology, where a transducer is placed on the mother's abdomen. The transducer emits sound waves that bounce off the fetal heart, and the reflected signals are received back. Electronic circuitry within the monitor compares the transmitted and received frequencies, detecting any differences that correspond to the fetal heartbeat.

Neonatal monitoring devices are medical tools used to observe and evaluate the vital health indicators of newborn babies, especially those born prematurely or with medical conditions necessitating specialized care. These instruments are vital in monitoring and managing the health of infants admitted to Neonatal Intensive Care Units (NICUs).

Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers

Rising preterm birth rates and technological advancements

The demand for the global fetal and neonatal monitoring devices market is driven by multiple factors.  The fetal and neonatal monitoring devices market is experiencing substantial growth, primarily driven by the rising rates of preterm births worldwide & technological advancements. Preterm delivery, which occurs before the completion of 37 gestational weeks, has emerged as a pressing global health issue, necessitating the development and adoption of advanced monitoring technologies to ensure the well-being of these vulnerable infants. Preterm infants are at a greater risk for illnesses and infections, which results in an increased need for monitoring technologies to effectively monitor their health conditions.

Rapid advancements in medical diagnostic equipment technologies are significantly enhancing the demand for fetal and neonatal heart monitors. These innovations, particularly in wireless, portable, and wearable devices, are transforming how healthcare providers monitor maternal and fetal health, leading to improved patient comfort and mobility.

Moreover, key player's strategies such as partnerships & collaborations would propel this market growth. For instance, in February 2024, Infosys Foundation, the philanthropic arm of Infosys, announced a collaboration with the Centre for Cellular and Molecular Platforms (C-CAMP) to launch the 'C-CAMP-Infosys Foundation Project Early Life'. This project aims to bolster maternity care for expectant mothers and newborns in Karnataka using innovative medical technologies. Infosys Foundation has committed ₹8.5 crore towards this project. A neonatal Continuous Positive Airway Pressure (CPAP) device, which provides respiratory support for newborns in distress, will be made available across critical care newborn units in district and taluk hospitals.

Similarly, in January 2024, Arab Health will showcase innovative technologies in labor delivery and neonatal care, introducing a new feature called the Smart Hospital and Interoperability Zone in collaboration with Cleveland Clinic Abu Dhabi. Located within the Healthcare Transformation sector, the zone will include four demonstration rooms, one of which will focus specifically on labor, delivery, and neonatal care. Visitors will gain insights into the latest advancements in birth-related technologies, such as electronic fetal monitoring, ultrasonography, blood pressure monitoring, and maternal/fetal pulse oximetry.

Restraints

Factors such as stringent regulatory requirements, high costs of advanced equipment, and limited awareness & training among people, are expected to hamper the market.

Market Segment Analysis

The global fetal and neonatal monitoring devices market is segmented based on product type, portability, end-user, and region.

The fetal monitoring devices segment accounted for approximately 67.8% of the global fetal and neonatal monitoring devices market share

The fetal monitoring devices segment is expected to hold the largest market share over the forecast period. These devices are a key component of the larger fetal and neonatal monitoring devices market. These specialized tools are essential for monitoring the health and well-being of unborn infants throughout pregnancy and during labor. They allow healthcare professionals to identify potential complications early and take timely action, ultimately promoting favorable outcomes for both mothers and their babies.

These devices utilize high-frequency sound waves to produce images of the fetus, enabling healthcare providers to assess growth, and development, and identify any potential abnormalities. Commonly referred to as cardiotocographs, these devices employ sensors positioned on the mother's abdomen to continuously track the fetal heart rate and uterine contractions. Fetal Doppler devices, on the other hand, leverage the Doppler effect to detect and enhance the fetal heartbeat, allowing healthcare professionals to monitor the baby's heart rate throughout pregnancy and during labor.

Moreover, key players' technological advancements and innovative product launches & approvals driving this segment's growth in the market. For instance, in February 2024, GE HealthCare announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Novii + Wireless Patch Solution. This maternal and fetal monitor noninvasively tracks and displays fetal heart rate, maternal heart rate, and uterine activity, providing care teams with real-time patient data. The wireless and belt-free design of Novii+ allows mothers greater mobility during labor, enhancing their experience. Research indicates that remaining upright and walking can help shorten the duration of labor.

Similarly, in January 2024, Bloomlife received FDA approval for its MFM-Pro device, marking a significant advancement in maternal and fetal monitoring technology. This device is designed as a prescription-based wearable that allows healthcare providers to monitor both maternal and fetal heart rates in various settings, including patients' homes and clinics.

Market Geographical Share

North America accounted for approximately 44.6% of the global fetal and neonatal monitoring devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing number of preterm and low-weight births, advanced technology in fetal and prenatal monitoring, and government initiatives and funding.

The Dimes Report Card in November 2023,  reveals a slight improvement in the U.S. preterm birth rate, which decreased from 10.5% in 2021 to 10.4% in 2022. However, this modest 1% decline still results in over 380,000 babies being born prematurely each year. The report also highlights that more than one-third of women have pre-existing medical conditions, such as diabetes, hypertension, and obesity, that significantly increase their risk of delivering preterm. Despite this small improvement, the preterm birth rate remains alarmingly high, earning the nation a concerning D+ grade for the second consecutive year.

Moreover, a major number of key players' presence, well-advanced healthcare infrastructure, innovative product launches, and investments in the  NICU would propel this market growth in this region. For instance, in May 2023, Adirondack Health celebrated the launch of its cutting-edge digital fetal heart monitoring system at the Stafford New Life Center, located at Adirondack Medical Center in the U.S. 

The new system, which replaces the previous paper-based system, was made possible by a generous $100,000 matching grant from the Countess Alicia Spaulding Paolozzi Foundation. Demonstrating its commitment to providing the highest quality of care for expectant mothers and their newborns. The new digital fetal heart monitoring system represents a significant investment in advanced medical technology, ensuring that patients receive the best possible care during this critical time.

Also, in January 2023, in the U.S. MetroHealth is set to unveil its advanced Birthing Center and Neonatal Intensive Care Unit (NICU) as part of a $1 billion transformation of its main campus in Cleveland's Clark-Fulton neighborhood. The center features ten birthing rooms designed to provide flexible options during labor. These rooms are enhanced with natural light and patient-controlled mood lighting in soothing colors to create a calming environment tailored to each patient's needs. Additionally, each labor and delivery room is equipped with a sophisticated wireless fetal monitoring system, and there is dedicated space for newborn care within the birthing rooms.

Market Segmentation

By Product Type

• Fetal Monitoring Devices 
  • Ultrasound Devices
  • Fetal MRI Systems 
  • Fetal Monitors 
  • Fetal Pulse Oximeters
• Neonatal Monitoring Devices
  • Pulse Oximeters
  • Blood Pressure Monitors
  • Cardiac Monitors
  • Integrated Monitoring Devices
  • Capnographs
  • Others

By Portability

• Portable Monitoring Devices
• Non-Portable Monitoring Devices

By End-User

• Hospitals
• Neonatal Clinics
• Obstetrics and Gynecology Clinics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • The rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Market Competitive Landscape

The major global players in fetal and neonatal monitoring devices include Cardinal Health, Koninklijke Philips N.V., GE HealthCare., Medtronic, Drägerwerk AG & Co. KGaA, Natus Medical Incorporated, Fisher & Paykel Healthcare Limited., Utah Medical Products, Inc., Vyaire Medical, Inc. and Masimo among others.

Key Developments

• In May 2024, Masimo announced that its Stork baby monitoring system has received clearance from the U.S. Food and Drug Administration (FDA) for over-the-counter (OTC) use with healthy infants up to 18 months old, without requiring a prescription. The FDA-cleared OTC version of Stork utilizes Masimo's advanced pulse oximetry technology, which is currently used to monitor over 10 million babies in hospitals annually.
• In September 2023, The National Institutes of Health (NIH) is launching the Rapid Acceleration of Diagnostics Technology (RADx Tech) Fetal Monitoring Challenge, which aims to award up to $2 million in cash prizes to foster the development of innovative diagnostic and monitoring technologies that can enhance fetal health outcomes, particularly in low-resource settings.

 Why Purchase the Report?

• To visualize the global fetal and neonatal monitoring devices market segmentation based on product type, portability, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points on all segments' fetal and neonatal monitoring devices market.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The global fetal and neonatal monitoring devices market report would provide approximately 62 tables, 52 figures, and 183 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies